Venus Concept Inc. (NASDAQ:VERO – Get Free Report) major shareholder Michael Willingham Masters sold 94,553 shares of the business’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $0.53, for a total value of $50,113.09. Following the completion of the sale, the insider now owns 17,059 shares in the company, valued at approximately $9,041.27. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
Michael Willingham Masters also recently made the following trade(s):
- On Monday, September 30th, Michael Willingham Masters sold 71,368 shares of Venus Concept stock. The stock was sold at an average price of $0.64, for a total value of $45,675.52.
Venus Concept Trading Down 10.2 %
Shares of Venus Concept stock opened at $0.45 on Friday. The stock has a market capitalization of $2.85 million, a P/E ratio of -0.07 and a beta of 0.51. Venus Concept Inc. has a 52-week low of $0.42 and a 52-week high of $2.43. The company has a debt-to-equity ratio of 9.72, a quick ratio of 1.30 and a current ratio of 1.99. The stock’s 50-day simple moving average is $0.61 and its 200 day simple moving average is $0.66.
Institutional Investors Weigh In On Venus Concept
An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC lifted its stake in shares of Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 666,702 shares of the company’s stock after purchasing an additional 333,366 shares during the quarter. Masters Capital Management LLC owned 10.49% of Venus Concept worth $522,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 87.41% of the company’s stock.
About Venus Concept
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
See Also
- Five stocks we like better than Venus Concept
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Trading Stocks: RSI and Why it’s Useful
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.